Health And Pharma

Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

Overcoming Resistance in Cancer Treatment with Cytokine Therapies

ONCOLife

Novel Biomarker-Driven Treatments with ADCs in NSC Lung Cancer Management

ONCOLife

Role of CGP Testing in the Management of Cancer Treatment and Personalized Care

Webinar

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

ONCOLife

Transforming Melanoma Treatment with DNA Plasmid Vaccine

ONCOLife

How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment

ONCOLife

FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer

ONCOLife

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

ONCOLife

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

Featured Articles

FDA Approves MI Cancer Seek Test as a Groundbreaking Tool for Targeted Cancer Therapy

9 November 2024

The FDA has approved Caris Life Sciences’ MI Cancer Seek, a pioneering diagnostic test combining Whole Exome and Whole Transcriptome Sequencing in one assay....

IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer

7 November 2024

FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic

21 October 2024

Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer

20 October 2024

FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer

19 October 2024

Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers

18 October 2024

AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma

17 October 2024

Trending Articles

Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries

Biotech | 11 October 2024

The Future of Oncolytic Viruses and Their Role in Cancer Treatment

ONCOLife | 3 October 2024

The Role of AI in the Future of Drug Discovery: Redefining Accuracy...

Digital Health | 2 October 2024

New AI Model VersAI™ Elevates AI Accuracy in Drug Discovery with Sparse Data

AI | 18 September 2024

ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer

Clinical Trials | 17 September 2024

ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5%

Clinical Trials | 16 September 2024

The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer

ONCOLife | 12 September 2024

European Commission Approves BRAFTOVI and MEKTOVI for Lung Cancer

ONCOLife | 4 September 2024

FDA Approves Breakthrough Device: Altius System to Tackle Chronic Amputation Pain

Medical Devices | 31 August 2024

Nipocalimab Submitted to FDA for Treatment of Generalized Myasthenia Gravis

FDA & EMA | 30 August 2024

FDA Approves TruSight Cancer Test for Matching Patients with Targeted Therapies

FDA & EMA | 2 September 2024

Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment

ONCOLife | 29 August 2024

First Lung Cancer Vaccine Trial for BioNTech's BNT116 Launched Across 7 Countries

ONCOLife | 25 August 2024

Next-Generation Weight Loss Therapeutic Nimacimab Enters Phase 2 Clinical Trial

Clinical Trials | 22 August 2024

Novel Cancer Drug PT217 Wins FDA Orphan Drug Status for Neuroendocrine Carcinoma

Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300

ONCOLife

19 August 2024

AI-Powered Treatment Success: LP-300 Shows Promise for Non-Smoker Lung Cancer

ONCOLife

12 August 2024

New Developments in Prostate Cancer: The Road to More Personalized Medicine

ONCOLife

26 July 2024

FDA Approves Neffy: First Nasal Spray for Emergency Allergic Reactions

FDA & EMA

10 August 2024

Mixed-Reality System, HipInsight, Receives FDA Approval for Hip Surgery

Merck Ends KeyVibe-008 Trial Over Safety Concerns: A Setback in Lung Cancer

ONCOLife

9 August 2024

Elevating Safety and Efficacy in Brain Tumor Treatment with the NB3 Laser Probe

ONCOLife

23 July 2024

Healthy Planet: How The Pharmaceutical Industry Can Reduce Its Emissions

Opinion

9 August 2024

The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan

Pharma

9 August 2024

Iptacopan, the First CI, Wins FDA Accelerated Approval for IgA Nephropathy

FDA Approves Vorasidenib as First Targeted Therapy for G2 IDH-Mutant Glioma

FDA & EMA

7 August 2024

Novel CAR T Cell Therapy Targets Brain Cancer's Hidden Pathways, Doubling Survival

ONCOLife

6 August 2024

The Impact of Comprehensive Genomic Profiling on Personalized Cancer Care

ONCOLife

17 July 2024

Novel Immunotherapy IMNN-001 Shows Extended Survival Rates for Ovarian Cancer

ONCOLife

3 August 2024